EcoDrugPlus

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSELUG00000014486
Gene Symbol: LOC105028617
3 Cross references
210 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSELUG00000009472
Gene Symbol: IKBKB
3 Cross references
198 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSELUG00000011592
Gene Symbol: IMPDH2
4 Cross references
202 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSELUG00000020686
Gene Symbol: LOC105022223
4 Cross references
259 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSELUG00000001819
Gene Symbol: LOC105020386
4 Cross references
258 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSELUG00000008208
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSELUG00000013713
Gene Symbol: LOC105022623
3 Cross references
207 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSELUG00000018619
Gene Symbol: INSR
3 Cross references
208 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSELUG00000017203
Gene Symbol: LOC105016672
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSELUG00000017508
Gene Symbol: IGF1RA
1 Cross references
206 Possible Orthologues:

Integrin Alpha-4

Ensembl ID : ENSELUG00000007006
Gene Symbol: LOC105006671
2 Cross references
164 Possible Orthologues:

Integrin Alpha-5

Ensembl ID : ENSELUG00000003792
Gene Symbol: LOC105022289
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).